Trends in adherence to secondary prevention medications in elderly post‐myocardial infarction patients
- 27 October 2008
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 17 (12), 1189-1196
- https://doi.org/10.1002/pds.1671
Abstract
Background Poor levels of medication adherence for patients with coronary heart disease (CHD) have been documented but it is unclear whether adherence has improved over time. Methods We assembled a retrospective cohort of lower‐income Medicare beneficiaries who were discharged from the hospital after their first acute myocardial infarction (MI) between 1 January 1995 and 31 December 2003. For patients prescribed a statin, ACEI/ARB, beta‐blocker, and all 3 of these medications after the hospital discharge, we evaluated medication adherence by determining the proportion of days covered (PDC) for each medication in the subsequent year. Results Our cohort consisted of a total of 33 646 patients. Adherence rates for statins and beta‐blockers, but not ACEI/ARB, increased significantly over time but remained suboptimal. For example, among those patients that received a statin after discharge, 38.6% were fully adherent with therapy in 1995 in contrast to 56.2% in 2003 (p value for trend p value for trend <0.001). Conclusions Our analysis demonstrates statistically significant but modest improvements in medication adherence for statins and beta‐blockers, but not ACEI/ARBs, among patients discharged from hospital after acute MI. Despite these improvements, rates of non‐adherence to these highly effective therapies remain extremely high. Given the health and economic consequences of non‐adherence, the development of cost‐effective strategies to improve medication adherence should be a clear priority. Copyright © 2008 John Wiley & Sons, Ltd.Keywords
This publication has 31 references indexed in Scilit:
- Should Patients Receive Secondary Prevention Medications For Free After A Myocardial Infarction? An Economic AnalysisHealth Affairs, 2007
- Heart Disease and Stroke Statistics—2006 UpdateCirculation, 2006
- Impact of Medication Adherence on Hospitalization Risk and Healthcare CostMedical Care, 2005
- ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction)Journal of the American College of Cardiology, 2004
- Expert consensus document on ?-adrenergic receptor blockersThe Task Force on Beta-Blockers of the European Society of CardiologyEuropean Heart Journal, 2004
- Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular diseaseThe Task Force on ACE-inhibitors of the European Society of CardiologyEuropean Heart Journal, 2004
- Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up studyHeart, 2002
- The TIMI risk score for unstable angina/non-ST elevation MI - A method for prognostication and therapeutic decision makingJama-Journal Of The American Medical Association, 2000
- The Treatment of Unrelated Disorders in Patients with Chronic Medical DiseasesThe New England Journal of Medicine, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsThe New England Journal of Medicine, 1996